STA
RGEN icon

Summit Trail Advisors’s Repligen RGEN Stock Holding History

Summit Trail Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Buy
11,473
+3,811
+50% +$532K 0.02% 786
2025
Q4 		$1.26M Buy
7,662
+388
+5% +$60.8K 0.02% 683
2025
Q3 		$972K Buy
7,274
+3,851
+113% +$468K 0.01% 852
2025
Q2 		$426K Buy
+3,423
New +$436K 0.01% 791

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Summit Trail Advisors's RGEN Position: Q1 2026 in Review

Summit Trail Advisors increased its Repligen (RGEN) stake by 50% in Q1 2026, buying an estimated $532K and bringing the position to 11,473 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #786.

Summit Trail Advisors first reported a position in RGEN in Q2 2025 and has held it in 4 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Summit Trail Advisors held 11,473 shares of Repligen worth $1.35M as of Q1 2026.
  • Summit Trail Advisors bought 3,811 Repligen shares in Q1 2026, an estimated $532K.
  • Repligen made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #786 holding.
  • Summit Trail Advisors first reported a position in Repligen in Q2 2025 and has held it in 4 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.